Intelligent Issue 07 | Page 9



Acino , a Swiss pharmaceutical company headquartered in Zurich , has announced the integration of Pharmax Pharmaceuticals , a UAE-based manufacturer and distributor of high-quality medications . Both companies are owned by ADQ – an Abu Dhabi-based investment and holding company .

With the integration of Pharmax , Acino will add over 100 employees and a GCC and EU GMP-certified manufacturing site , complementing its operational capabilities and expanding its growing international footprint . Equipped to manufacture various dosage forms , including tablets , capsules , inhalers , injectables and topicals , the newly added facility adheres to the high-quality standards set by the regulatory authorities in the UAE and Europe .
“ The integration of Pharmax Pharmaceuticals into Acino will accelerate our efforts towards becoming a leading provider of high-quality pharmaceuticals in the Middle East and beyond ,” said Sunil Bhilotra , Managing Director and Interim CEO of Acino . “ We will advance our ability to distribute high-quality medicines to markets across the globe and achieve even greater levels of growth and innovation across the pharma value chain .”
“ Our industry is continuously evolving and this step will help both organisations deliver continued value to our patients and customers ,” added Madhukar Tanna , CEO of Pharmax . “ By integrating our workforce , products and operations , we are building a stronger platform for the future .”
The combined company will be able to leverage synergies across main therapeutic areas and share best practices , advancing product development capabilities and further strengthening Acino ’ s robust commercial performance .


Research from BenchSci , a world leader in AI solutions for drug discovery , has revealed new insights into the attitudes and preferences of AI , Machine Learning and data professionals in the UK when looking for new employment opportunities .

“ While the global economy continues to face challenges and instability , competition for tech talent is not slowing down ,” said Vanessa Ribreau , Chief People Officer at BenchSci .
“ This research conducted with one of the most soughtafter groups in terms of tech talent clearly shows that well-recognised names and generous salaries are no longer enough to entice the brightest talent .
“ Talent is willing to invest their personal capital in the form of time , energy and labour for the right company , but only for a healthy return on their investment . Career progression and personal development are a must . The companies that will stay ahead are the ones who think of their employees as key stakeholders , not as a means to an end . Being intentional about culture is the best way to create an environment where that ' s possible ."
The research asked AI and ML engineers to rank what they prioritised when looking for a new employer from stability , work environment , work arrangements , diversity , impact , mission , organisational benefits , flexibility , progression and remuneration . The latter three were ranked highest across all genders at 37 %, 32 % and 32 % respectively .
www . intelligenthealth . tech 9